Status:
RECRUITING
Metabolic and Immunological Phenotyping in Patients With Cancer
Lead Sponsor:
CCTU- Cancer Theme
Conditions:
Cancer
Non-Hematologic Malignancy
Eligibility:
All Genders
18+ years
Brief Summary
An observational study to investigate cachexia in participants with non-haematological cancer.
Detailed Description
A single-centre, non-randomised, observational study. This study will investigate the systemic metabolic and immunological changes that occur in cachexia. The aim is to better understand the mechanism...
Eligibility Criteria
Inclusion
- Have given written informed consent to participate
- Be aged 18 years or over at the time of signing the informed consent form
- Have a histological or cytological diagnosis of a non-haematological cancer
- Are willing and able to comply with study procedures and visits
Exclusion
- Active infection, as determined by the investigator based on clinical symptoms and / or fever and / or requirement for antibiotics
- Current treatment with chemotherapy, oral steroids or other immunosuppressive drugs (within 7 days of baseline investigations or during the study phase)
- Significant acute, chronic or psychiatric condition or laboratory abnormality which in the judgment of the investigator would place the patient at undue risk or interfere with the study.
- Intolerance to dairy products
- Women, who are pregnant, plan to become pregnant or are lactating
Key Trial Info
Start Date :
December 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04285242
Start Date
December 7 2021
End Date
June 1 2024
Last Update
February 2 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust,
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ
2
Cambridge University Hospitals NHS Foundation Trust
Cambridge, England, United Kingdom, CB2 2QQ